Panbela Therapeutics Inc (PBLA) Stock Price & News

All values in USD	Dec 2023	Mar 2024	Jun 2024	Sep 2024
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	6.05M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	-	1.11M
Operating expense	-	-	-	7.16M
Total operating expenses	-	-	-	7.16M
Operating income	-	-	-	-7.16M
Other non operating income	-	-	-	-
EBT including unusual items	-	-	-	-7.17M
EBT excluding unusual items	-	-	-	-7.17M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-	-	-	-7.17M
Net profit margin	-	-	-	-
Earnings per share	-65.90	-2.28	-1.47	-
Interest and investment income	-	-	-	-
Interest expense	-	-	-	-442.00K
Net interest expenses	-	-	-	-442.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance